Canada Healthcare August 2020 –

Written by  //  November 21, 2020  //  Canada, Health & Health care  //  No comments

Canada Health Act
CIHR Dementia Research Strategy
Canada Healthcare June 2015- July 2020

What you need to know as we get closer to a COVID-19 vaccine
The potential for a vaccine brings with it hope that the pandemic will end, but naturally raises questions
(CBC) Dr. Howard Njoo, the country’s deputy chief public health officer, has said that if the vaccines are approved by Health Canada, he’s hopeful that the majority of Canadians could be vaccinated by the end of 2021.
But amid the optimism, a new vaccine naturally raises lots of questions, from how it works to who will get it first in a country of more than 35 million people.

29 September
Feds announce plan to buy 7.9 million rapid COVID tests as Health Canada defends slow response
(CBC) The federal government today announced a plan to buy 7.9 million point-of-care COVID-19 tests in the months ahead — and defended a Health Canada regulatory process that has left the country with few rapid testing devices to deploy as cases mount.
To date, the vast majority of tests have been done at public health clinics, with samples then sent to laboratories for analysis — a process that can take days.
A point-of-care test could be administered by trained professionals in other settings. The molecular test Canada is looking to buy — the ID NOW — can produce results from a nasal swab in as little as 13 minutes.
While Canada has announced this purchase from a well-regarded U.S. firm, the test itself has not yet been approved by Health Canada for distribution. [Public Services and Procurement Minister Anita] Anand said she couldn’t state when these devices will be deployed to provinces like Ontario and Quebec, where hours-long lines have been an ongoing concern.
While the U.S. Food and Drug Administration has so far approved dozens of rapid testing devices, Health Minister Patty Hajdu said such tests would only be rolled out in Canada once regulators here are sure they are safe to use.

8 September
Beyond long-term care: The benefits of seniors’ communities that evolve on their own
(The Conversation) The global COVID-19 pandemic has shown Canadians that we need to think differently about how we support older adults. The media and all levels of government have focused heavily on long-term care, and rightly so. However, the vast majority of older adults live at home and plan to remain there for as long as possible.
In a July 2020 Home Care Ontario survey of older adults, 93 per cent of the 1,000 respondents indicated their desire to stay in their own home. No one identified long-term care as part of their future housing plans. Simply put, although necessary for some, long-term care is not where most people choose to live.
It had been clear well before the pandemic that long-term care is costly and woefully inadequate to meet the needs of Canada’s aging population. It is crucial to expand the conversation to consider what other housing solutions exist and how they can be implemented.
Essential to the success and acceptability of any housing alternative is the need for older adults to maintain a sense of autonomy and independence, be actively engaged in decisions affecting themselves and their community and have the opportunity to build social networks that can ultimately support one another.

4 – 5 August
Ottawa frees up $3.3-billion for provincial efforts to mitigate COVID-19 spread
The federal government is moving ahead with plans to help provinces and territories shore up their defences against COVID-19 by freeing up billions of dollars to make schools and hospitals more pandemic resistant and expand outdoor public spaces.
Infrastructure Minister Catherine McKenna unveiled details of the plan Wednesday, which followed weeks of talks between Ottawa and provincial and territorial governments — as well as years of criticism about the slow pace of the Liberals’ infrastructure spending.
Canada signs COVID-19 vaccine supply deals with Pfizer and Moderna
Canada is negotiating deals with pharmaceutical giant Pfizer and U.S.-based biotech firm Moderna to secure millions of doses of their experimental COVID-19 vaccines, in case either is approved for wide-scale use.
But Procurement Minister Anita Anand won’t say yet how much Canada is spending or how many doses of either vaccine candidate Canada will get because she says Canada is in talks with other domestic and international firms to secure doses of their experimental vaccines as well.
Physical distancing, mask-wearing could be in place for 2-3 years even with vaccine, Tam warns
COVID-19 vaccine won’t be a ‘silver bullet,’ chief public health officer says
(CBC) Dr. Theresa Tam used her briefing on Tuesday in Ottawa to temper expectations about the speed and effectiveness of a vaccine. She reiterated the importance of physical distancing, proper hand hygiene and mask-wearing, and attempted to dissuade any notion that a vaccine will make life go back to the way it was in a couple of months.Tam said it’s unclear at this stage how effective a vaccine will be. She said key questions remain about the degree and duration of immunity a vaccine will provide, the dosage that will be needed and whether it will prevent people from getting infected altogether or simply prevent severe illness requiring hospitalization.
There are more than 166 vaccines at various stages of preclinical and clinical (human) testing across the globe right now, the World Health Organization says. U.S. and European experts say under an optimistic scenario, the first of those vaccines could complete testing and get approval for distribution next year.
Tam warned that even once a vaccine is tested and deemed to be both safe and effective, there will be challenges with distributing it widely to those who need it.

Leave a Comment

comm comm comm